Xuanyu Zhang
Hangzhou, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 15 publications
Liver transplantation for hepatocellular carcinoma arising in non-cirrhotic liver: a national-wide retrospective cohort study with propensity score matching analysis in China.
Journal: Hepatobiliary surgery and nutrition
Published: July 27, 2024
Utilization of hepatitis B virus surface antigen positive grafts in liver transplantation: A matched study based on a national registry cohort.
Journal: Journal of gastroenterology and hepatology
Published: October 08, 2021
Combination of Early Allograft Dysfunction and Protein Expression Patterns Predicts Outcome of Liver Transplantation From Donation After Cardiac Death.
Journal: Frontiers in medicine
Published: September 13, 2021
Phosphorylation of PED/PEA-15 at Ser116 and phosphorylation of p27 at Thr187 indicates a poor prognosis in hepatocellular carcinoma.
Journal: Oncology letters
Published: December 24, 2019
Diagnostic value of glypican-3, arginase-1 and hepatocyte paraffin antigen -1 in differentiating hepatocellular carcinoma from intrahepatic cholangiocarcinoma.
Journal: Translational cancer research
Published: July 21, 2019
High Expression of Human AugminComplex Submit 3 Indicates Poor Prognosis and Associates with Tumor Progression in Hepatocellular Carcinoma.
Journal: Journal of Cancer
Published: July 05, 2018
lncRNA DRHC inhibits proliferation and invasion in hepatocellular carcinoma via c-Myb-regulated MEK/ERK signaling.
Journal: Molecular carcinogenesis
Published: April 01, 2018
Peroxiredoxins in inflammatory liver diseases and ischemic/reperfusion injury in liver transplantation.
Journal: Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association
Published: September 25, 2017
Metformin ameliorates arsenic trioxide hepatotoxicity via inhibiting mitochondrial complex I.
Journal: Cell death & disease
Published: July 12, 2017
CR6-interacting factor 1 inhibits invasiveness by suppressing TGF-β-mediated epithelial-mesenchymal transition in hepatocellular carcinoma.
Journal: Oncotarget
Published: May 13, 2017
Donor miR-196a-2 polymorphism is associated with hepatocellular carcinoma recurrence after liver transplantation in a Han Chinese population.
Journal: International journal of cancer
Published: February 05, 2015
Last Updated: 09/26/2026